Needleless Ebola vaccine succeeds in monkeys; Vanderbilt University Medical Center becomes first scientific hub for Human Vaccines Project;

> The University of Texas Medical Branch at Galveston and the NIH tested an inhaled Ebola vaccine, which showed promise in monkeys and should move into human trials soon. Story

> Vanderbilt University Medical Center has become the first scientific hub for the Human Vaccines Project, incubated by the International AIDS Vaccine Initiative. Release

> Researchers at the University of Georgia have developed new tools to study the parasite that causes cryptosporidiosis. They hope to use them to develop treatments and vaccines for the disease. More

Suggested Articles

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

BioNTech expects a quick turnaround once the transaction closes and plans to produce up to 250 million doses of BNT162b2 in the first half of 2021.

Participation in clinical trials among Black people is low, FDA statistics show, even as drugmakers prioritize including them in COVID-19 shot trials.